3 bottles of galafold

Ended Awarded Last action

Contract number
36C24925F0166
Awardee
Awarding agency
Obligated
$65,674

Award facts

Contract value 100% obligated
$65,673.63 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Philadelphia, PA 19104, USA

Award details come from SAM.gov/FPDS.

About this award

This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc. The contract is for the supply of 3 bottles of Galafold, an enzyme replacement therapy used to treat Fabry disease, a rare genetic disorder. The contract, valued at $65,673.63, is part of a larger Federal Supply Schedule (FSS) contract (36F79724D0185) between the VA and Amicus Therapeutics US, LLC, which is valid through August 31, 2029. The FSS contract, under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, allows various VA Veterans Integrated Service Networks (VISNs) to place task orders for pharmaceutical products, with Galafold being the primary product supplied. This contract supports the VA's mission to provide specialized healthcare services and medications to veterans, ensuring continuous access to critical treatments for rare diseases. The contract has no set-aside designation.

Quick answers

Who was awarded contract 36C24925F0166?

36C24925F0166 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 9 (Veterans Health Administration) on April 1, 2025.

How much is contract 36C24925F0166 worth?

The government has obligated $65,674 on 36C24925F0166.

Is contract 36C24925F0166 an order under another contract?

Yes. 36C24925F0166 is a delivery order under 36F79724D0185, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24925F0166 competed?

The extent of competition for 36C24925F0166 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award